Rush to Robotic Surgery Outpaces Medical Evidence, Critics Say
Hospitals are hyping better outcomes with the robot, but economics and marketing may be driving the push
Richard Mark Kirkner
Payers attracted by the siren song of this cost-cutting strategy don’t always appreciate its risks and complications
Peter Boland, PhD ; David Gibson, MD
Fine tuning, not abandoning PSA testing, is the approach
Thomas Reinke
Humana CMO looks to Medicare Advantage and quality scores to drive the company toward new relationships with members, providers, and the government
John Marcille
An instance where the ubiquitous “more research is needed” very much sums up the debate
Frank Diamond
Departments
Estimates for Sovaldi place it in an expensive neighborhood for medications, but the virus it fights moves slowly
There’s still no “magic pill,” but new medications abound. With the disease uncontrolled in millions, it’s time to get utilization management just right.
Kaiser Permanente patients who feel that they are part of the care decision process are more likely to stay on antidepressants
Otezla (apremilast) sparks hope about treatment, but also concern about depression and suicidal thoughts
News & Commentary
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.